Evaluation of Cross Protective Efficacy of Commercial Vaccines against Mannheimia haemolytica in Mice

Mannheimia haemolytica together with Pasteurella multocida represents as a major bacterial causative agent of cattle, sheep and goats respiratory diseases and its one of the most important causes for economic losses to these animals .Commercially available vaccines were used to prevent infections ca...

Full description

Bibliographic Details
Main Author: Waffa A. Ahmed
Format: Article
Language:English
Published: University of Baghdad, College of Veterinary Medicine 2019-08-01
Series:The Iraqi Journal of Veterinary Medicine
Subjects:
Online Access:https://jcovm.uobaghdad.edu.iq/index.php/Iraqijvm/article/view/487
_version_ 1818788673742700544
author Waffa A. Ahmed
author_facet Waffa A. Ahmed
author_sort Waffa A. Ahmed
collection DOAJ
description Mannheimia haemolytica together with Pasteurella multocida represents as a major bacterial causative agent of cattle, sheep and goats respiratory diseases and its one of the most important causes for economic losses to these animals .Commercially available vaccines were used to prevent infections caused by P. multocida and M. haemolytica. Thus, the aim of the present study was to evaluate the cross protection efficacy of two vaccines to protect mice against M.haemolytica, studying humeral immunity, using Enzyme-Linked Immunosorbent Assay. Forty five mice were divided into three equal groups, group one and two were inoculated subcutaneously  4μl\JOVAPAST® and 1μl of Al-kindy vaccines respectively, while the third group was with 0.5 ml sub cutaneous PBS. LD50for M.haemolytica was estimated as 2× 106 cfu \ml and challenge test was conducted by dropping 0.05 ml 2× 106 cfu \ml intranasally after three weeks of immunization for the three groups. The results of Enzyme-Linked Immunosorbent Assay, showed significant increase of antibody titters at (P<0.01) in (group 1 and 2) after first and second weeks post immunization, in comparison with control group. Also, the re-isolation of M.haemolytica from lungs tissue of all groups after challenged were positive with significant difference between control and immunized group, control group was 4× 108 cfu ∕ml which was higher than immunized group one and group two,which were 2.5×104 cfu∕ml and 3,5×105 cfu∕ml respectively after 24 hour of vaccine. In conclusion, the two commercial vaccines showed good cross protection efficacy against M. haemolytica, but JOVAPAST® vaccine showed higher efficacy than Alkindy vaccine, as that it contain  two  heterologous  killed strains and providing the basis for production a vaccine from the two  pathogen of local strains.
first_indexed 2024-12-18T14:27:25Z
format Article
id doaj.art-42b50605a25e46dba9fb911f739b0f4a
institution Directory Open Access Journal
issn 1609-5693
2410-7409
language English
last_indexed 2024-12-18T14:27:25Z
publishDate 2019-08-01
publisher University of Baghdad, College of Veterinary Medicine
record_format Article
series The Iraqi Journal of Veterinary Medicine
spelling doaj.art-42b50605a25e46dba9fb911f739b0f4a2022-12-21T21:04:40ZengUniversity of Baghdad, College of Veterinary MedicineThe Iraqi Journal of Veterinary Medicine1609-56932410-74092019-08-0143110.30539/iraqijvm.v43i1.487Evaluation of Cross Protective Efficacy of Commercial Vaccines against Mannheimia haemolytica in MiceWaffa A. Ahmed0College of Veterinary Medicine, Baghdad UniversityMannheimia haemolytica together with Pasteurella multocida represents as a major bacterial causative agent of cattle, sheep and goats respiratory diseases and its one of the most important causes for economic losses to these animals .Commercially available vaccines were used to prevent infections caused by P. multocida and M. haemolytica. Thus, the aim of the present study was to evaluate the cross protection efficacy of two vaccines to protect mice against M.haemolytica, studying humeral immunity, using Enzyme-Linked Immunosorbent Assay. Forty five mice were divided into three equal groups, group one and two were inoculated subcutaneously  4μl\JOVAPAST® and 1μl of Al-kindy vaccines respectively, while the third group was with 0.5 ml sub cutaneous PBS. LD50for M.haemolytica was estimated as 2× 106 cfu \ml and challenge test was conducted by dropping 0.05 ml 2× 106 cfu \ml intranasally after three weeks of immunization for the three groups. The results of Enzyme-Linked Immunosorbent Assay, showed significant increase of antibody titters at (P<0.01) in (group 1 and 2) after first and second weeks post immunization, in comparison with control group. Also, the re-isolation of M.haemolytica from lungs tissue of all groups after challenged were positive with significant difference between control and immunized group, control group was 4× 108 cfu ∕ml which was higher than immunized group one and group two,which were 2.5×104 cfu∕ml and 3,5×105 cfu∕ml respectively after 24 hour of vaccine. In conclusion, the two commercial vaccines showed good cross protection efficacy against M. haemolytica, but JOVAPAST® vaccine showed higher efficacy than Alkindy vaccine, as that it contain  two  heterologous  killed strains and providing the basis for production a vaccine from the two  pathogen of local strains.https://jcovm.uobaghdad.edu.iq/index.php/Iraqijvm/article/view/487P. multocida , M. haemolytica, vaccine, ELISA
spellingShingle Waffa A. Ahmed
Evaluation of Cross Protective Efficacy of Commercial Vaccines against Mannheimia haemolytica in Mice
The Iraqi Journal of Veterinary Medicine
P. multocida , M. haemolytica, vaccine, ELISA
title Evaluation of Cross Protective Efficacy of Commercial Vaccines against Mannheimia haemolytica in Mice
title_full Evaluation of Cross Protective Efficacy of Commercial Vaccines against Mannheimia haemolytica in Mice
title_fullStr Evaluation of Cross Protective Efficacy of Commercial Vaccines against Mannheimia haemolytica in Mice
title_full_unstemmed Evaluation of Cross Protective Efficacy of Commercial Vaccines against Mannheimia haemolytica in Mice
title_short Evaluation of Cross Protective Efficacy of Commercial Vaccines against Mannheimia haemolytica in Mice
title_sort evaluation of cross protective efficacy of commercial vaccines against mannheimia haemolytica in mice
topic P. multocida , M. haemolytica, vaccine, ELISA
url https://jcovm.uobaghdad.edu.iq/index.php/Iraqijvm/article/view/487
work_keys_str_mv AT waffaaahmed evaluationofcrossprotectiveefficacyofcommercialvaccinesagainstmannheimiahaemolyticainmice